SEC Sues Founders of Bankrupt Human Microbiome Testing Firm uBiome For Fraud
The US Securities and Exchange Commission alleges that uBiome's founders misled investors in order to close a Series C financing round in 2018.
uBiome Files for Chapter 7 Liquidation
The company had previously declared Chapter 11 bankruptcy, which would have enabled it to reorganize to stay afloat and pay its creditors over time.
uBiome Declares Bankruptcy, Offers Assets for Sale
The San Francisco-based microbial genomics firm will sell off its product lines, testing labs, IP, and data within the next three months.
uBiome Shakes Up Management; Launches Investigation Into Billing Practices
The moves come in the wake of an FBI search of the company's San Francisco office as part of an investigation into its billing practices.
uBiome, University of Louisville Partner on IBD Study
The partners aim to determine whether the microbiome can be used to predict patient responses to certain inflammatory bowel disease therapies.